Showing results (51-60 of 1,707) with videos related to
Sort By:
Pageof 171
Human Vaccines & Immunotherapeutics|November 27, 2014
The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccinationKristin Hollister, Yuxin Chen, Shixia Wang, et al.Human Vaccines & Immunotherapeutics|November 1, 2012
DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in ChinaMingshun Zhang, Lu Zhang, Chunhua Zhang, et al.Journal of Virology|July 13, 2018
Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic InfectionKun-Wei Chan, Ruimin Pan, Matthew Costa, et al.Plos One|November 19, 2010
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodiesMichael Vaine, Shixia Wang, Qin Liu, et al.Vaccine|April 8, 2004
Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse modelFangjun Liu, Innocent Mboudjeka, Siyuan Shen, et al.Journal of Virology|December 17, 2013
A novel DDB2-ATM feedback loop regulates human cytomegalovirus replicationXiaofei E, George Savidis, Christopher R Chin, et al.Journal of Virology|March 18, 2011
Two closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolatesMichael Vaine, Maria Duenas-Decamp, Paul Peters, et al.Current HIV Research|August 12, 2008
Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolatesZuhu Huang, Arthur Chou, Jonathan Tanguay, et al.Current Drug Targets. Infectious Disorders|June 25, 2005
Application of the polyvalent approach to HIV-1 vaccine developmentJulia L Hurwitz, Karen S Slobod, Tim D Lockey, et al.Virology Journal|May 4, 2011
Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infectionJun Li, Yaping Han, Ke Jin, et al.Pageof 171